Prescient Therapeutics Ltd (PTX) — Cash Flow Quality Index
Prescient Therapeutics Ltd (PTX) has a Cash Flow Quality Index of 0.07x as of June 2013. Operating cash flow of AU$32.65K is below net income of AU$446.75K, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Prescient Therapeutics Ltd generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Prescient Therapeutics Ltd Cash Flow Quality Index (2013–2013)
Historical Cash Flow Quality Index for Prescient Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Prescient Therapeutics Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Prescient Therapeutics Ltd (2013–2013)
Year-by-year earnings quality comparison for Prescient Therapeutics Ltd. For live market cap and the full company financial profile, see market value of Prescient Therapeutics Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2013 | -0.02x | AU$-29.18K | AU$1.79 Million | — |